PSMD1 and infection: Taking into consideration the experimental results showing that an intravenously injected S1 protein can easily cross the murine blood–brain barrier and enter the parenchymal tissue and interstitial fluid spaces of the brain [41], as well as its persistence in circulation long after infection, we can suggest that the circulating S1 is more likely to cause neurological complications than the virus itself.